Current stock page

Stock Analysis

Banco Macro S.A. (BMA) Stock Analysis

Banco Macro S.A. (BMA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

BMA Stock Analysis Summary

Banco Macro S.A. (BMA) currently has an AIQ Score of 47/100, indicating a bearish setup. Quality is the strongest factor at 71/100. Momentum is the weakest current factor at 18/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

BMA at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$56.86
AIQ Score47/100
Overall ViewBearish
Technical Analysis ConsensusStrong Sell
Market Cap$3.63B
P/E Ratio (TTM)14.4
Forward P/E—
EPS (Q2 FY2026)$3,193.40
Revenue (Q2 FY2026)$1.47T
Dividend Yield (TTM)6.23%
Beta1.65
Volume260.15K
52-week range$54.57-$106.15
RSI 1435.21
50-Day SMA$66.54
200-Day SMA$78.69
Analyst Price Target$91.00
Next EarningsNov 25, 2026
As of Nov 13, 2026 · Market close

BMABanco Macro S.A.

Financial Services / Banks - Regional

Low Priority

Relative Laggard

BearishEdge 2/10
$56.86+$1.63 (+2.95%)

Latest quote

  • Momentum
    18
  • Value
    61
  • Quality
    71
  • Risk resilience
    49
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

BMA Stock Analysis Summary

Banco Macro S.A. (BMA) currently has an AIQ Score of 47/100, indicating a bearish setup. Quality is the strongest factor at 71/100. Momentum is the weakest current factor at 18/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, BMA has AIQ Score of 47/100 with Quality base of 71/100 and fading Momentum at 18/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Quality (71/100) leads while Momentum (18/100) lags. This cross-factor spread creates entry timing uncertainty.

Financial Services · 2.95% stock move · BMA classified in Banks - Regional.

Current Evidence

BearishBMA is in a bearish AIQ regime; Quality is the strongest visible factor at 71/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is BMA Bullish or Bearish Right Now?

BMA currently has a bearish overall setup. Quality is the strongest factor at 71/100, while Momentum is weakest at 18/100. The current evidence suggests a bearish setup.

Bull Case
  • - Quality is supportive at 71/100.
  • - Analyst target implies +60.04% upside from the latest quote.
Bear Case
  • - Momentum is weak at 18/100.
  • - Risk Resilience is weak at 49/100.
  • - Price is -27.74% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (35 vs 5).

Current Consensus

BMA's Technical Analysis Consensus is currently Strong Sell, with 5 buy, 6 neutral, and 35 sell votes. BMA's 14-day RSI is 35.21, which places the stock in a weaker momentum range. BMA's beta is 1.65, indicating greater market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in BMA?

The largest recent change in BMA is Value moving up by 3.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.

AIQ Score
+1.0
Momentum
+1.0
Quality
+0.0
Risk
-1.0

What Would Change the BMA Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

BMA Decision Framework

Public evidence layers, setup checks, and risk context for Banco Macro S.A..

Banco Macro S.A. (BMA) Stock Analysis

Banco Macro S.A. has an AIQ Score of 47/100 in a Bearish regime. Quality is strongest at 71/100. Beta is 1.65, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextBMA is in a Bearish AIQ regime with score 47/100.
Signal ConflictThe primary conflict is that quality leads at 71/100 while momentum lags at 18/100.
Factor EvidenceMomentum 18/100 · Value 61/100 · Quality 71/100 · Risk 49/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Quality is the strongest factor at 71/100.

TimingFail

Momentum is 18/100 and RSI (14) is 35.2.

Regime fitFail

BMA is in a Bearish regime at 47/100.

Risk controlFail

Risk factor is 49/100 with beta 1.65 and annual volatility 50.56%.

ConflictWait

Current conflict: quality leads at 71/100 while momentum lags at 18/100.

AIQ Score
47/100
Price
$56.86
Beta
1.65
RSI (14)
35.2

BMA Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

BMA Fundamentals

BMA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$1.47T
Net income
$204.08B
Free cash flow
$575.25B
View full BMA fundamental analysis

BMA Technical Analysis

BMA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
35.21
Price vs SMA-50
-14.55%
View full BMA technical analysis

BMA Stock Catalysts

Track BMA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Nov 25, 2026
Analyst target
$91.00
News items
1
View BMA earnings and stock catalysts

BMA Dividend Analysis

BMA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
3.50%
Annual dividend
$1.99
Payout ratio
31.76%
View BMA dividend history and analysis

BMA Financial Data

BMA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$1.47T
EPS
$3,193.40
Periods
8
View BMA financials

BMA Risk Analysis

BMA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.65
Risk score
49/100
1Y volatility
50.56%
View BMA risk analysis

BMA Stock News

BMA stock news, market tone, recent headlines, and catalyst context.

News items
1
Updated
Nov 15, 2026
Sentiment
—
Read BMA stock news

BMA vs Banks - Regional Peers

Current peer cohort: BMA · BSAC · BUSE · CASH · CBU. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
BMA
Current stock
47/10061/10018/10049/100-0.5850.56%Current
BSAC
Banco Santander-Chile
49/10015/10053/10076/1000.3329.18%BMA vs BSAC
BUSE
First Busey Corporation
66/10072/10060/10089/1000.9921.44%BMA vs BUSE
CASH
Pathward Financial, Inc.
58/10047/10034/10076/1000.3329.06%BMA vs CASH
CBU
Community Bank System, Inc.
54/10019/10055/10085/1000.5722.23%BMA vs CBU
Pairwise Compare links: BSAC · BUSE · CASH · CBUBMA vs BSACBMA vs BUSEBMA vs CASHBMA vs CBUCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a BMA stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for BMA: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
14.4
As of Nov 13, 2026
Revenue growth
4.10%
Gross margin
56.90%
Current debt / equity
0.27
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$1.47T
Quarter net income
$204.08B
Quarter free cash flow
$575.25B

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Bearish
RSI 14
35.21
MACD
-2.83

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
49/100
Beta
1.65
Annual volatility
50.56%
Max drawdown
-47.25%

BMA Stock FAQ

What is BMA stock price today?

Banco Macro S.A.'s current stock price is $56.86. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is BMA bullish or bearish right now?

BMA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is BMA's market cap?

BMA's market cap is $3.63B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is BMA's current P/E ratio?

BMA's current P/E ratio is 14.4 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is BMA's RSI?

BMA's 14-day RSI is 35.21 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is BMA above its 50-day and 200-day moving averages?

BMA is -14.55% from its 50-day SMA and -27.74% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is BMA's next earnings date?

BMA's next earnings date is currently listed as Nov 25, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does BMA pay a dividend?

BMA's dividend yield is 6.23% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.